Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Common Equity (2018 - 2025)

Health Catalyst's Common Equity history spans 8 years, with the latest figure at $245.8 million for Q4 2025.

  • For Q4 2025, Common Equity fell 32.7% year-over-year to $245.8 million; the TTM value through Dec 2025 reached $245.8 million, down 32.7%, while the annual FY2025 figure was $245.8 million, 32.7% down from the prior year.
  • Common Equity reached $245.8 million in Q4 2025 per HCAT's latest filing, down from $331.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $549.2 million in Q3 2021 to a low of $245.8 million in Q4 2025.
  • Average Common Equity over 5 years is $385.6 million, with a median of $371.9 million recorded in 2023.
  • Peak YoY movement for Common Equity: skyrocketed 89.1% in 2021, then crashed 32.7% in 2025.
  • A 5-year view of Common Equity shows it stood at $522.1 million in 2021, then fell by 18.6% to $425.0 million in 2022, then decreased by 13.67% to $366.9 million in 2023, then dropped by 0.47% to $365.2 million in 2024, then plummeted by 32.7% to $245.8 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Common Equity are $245.8 million (Q4 2025), $331.9 million (Q3 2025), and $347.5 million (Q2 2025).